April 12 (Reuters) - Valeant Pharmaceuticals International Inc said it received a notice of default from its bond holders as a result of its failure to file its annual report on time.
The Wall Street Journal reported earlier on Tuesday that Centerbridge Partners LP intends to call a default.
The move would start a 60-day period during which the embattled drugmaker would have to file its annual report or potentially be forced to repay the bonds early, the WSJ reported. (on.wsj.com/1TPIVpH)
Reporting by Rosmi Shaji in Bengaluru